On Monday, I convened a meeting to determine the next steps following the success of the CAPRISA trial, which showed the world that a microbicide could help prevent HIV transmission in women.  Together with both public and private sector colleagues, we defined a way forward over the next two years to expedite licensure and prepare for the introductory phase of the gel or other ARV-based microbicides. I will  also  convene  an additional meeting  of technical experts in the field to  discuss how to aggressively roll out microbicide treatments to those most in need.  We have a shared responsibility to build on the successes achieved to date by making smart investments that will ultimately save more lives in the future.